TensorTip™ COG™ non-invasive needle-free Combo Glucometer device from Israel based Cnoga to read blood glucose levels
Currently, a diabetes patient is checking blood sugar or glucose levels for multiple times in a day with a painful finger-pricking procedure. Scientists during the last several years are trying to develop an innovative and non-invasive device, which can provide blood sugar or glucose levels accurately, quickly and easily. They successfully developed blood glucose measuring devices such as needle sensors. But still, these devices require insertion of sensors under the skin and the sensor will have to be replaced regularly.
Cnoga Medical Ltd company, Caesarea, a North-central Israel based startup has developed a TensorTip™ COG™ glucometer device, which is a first commercially available non-invasive needle-free combo product to read blood sugar or glucose levels accurately for type 2 diabetes (T2D) or pre-diabetes patients. Another model for type 1 diabetes (T1D) patient is under development.
The product uses light-emitting-diodes (LED), a camera, a glucose meter (which is approved in several countries), supporting algorithms and software programs. The product is also equipped with an add-on regular blood sugar meter. The user can use regular test strips to confirm device reading in case of unclear results or during an emergency.
The user needs to insert his finger into the device for around 40 seconds to measure blood glucose levels. The device uses a camera sensor to detect the changes in the LED light reflected from a finger. The blood glucose level data will be displayed on the monitor. The data can be sent through the cloud or cellphone to health care center.
The product is undoubtedly a non-invasive product to read blood sugar levels for an unlimited number of times every day. There is no need to replace disposable parts. The product can be used for more than two years. The product is economical when the entire period of use was considered. But the product requires calibration by finger pricking with a needle-based device for a few times a day during the first week.
The product has successfully undergone two clinical studies in Germany. Those trials have validated the device technology, performance and accuracy. Trials were conducted on adults with the product. The device is not yet approved for the usage among children. The COG™ or TensorTip™ device blood sugar reading results are similar to the blood sugar reading devices using needle sensors.
The device got approvals or certifications from China, Brazil and European Union. The Cnoga Medical Ltd Company is planning for US FDA approval in the current year. The price of the product is between $1,000 to $1,500 and it is available on the company website.
The company has plans to develop a pocket-sized all-in-one product called MTX to measure parameters which require invasive tests such as.
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. Published article is not a medical advice by the OWNER of "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.